Table 2. The sensitivity of serum miR-223-3p, AFP and combination in diagnosis of HCC according to tumor staging.

BCLC Staging	miR-223-3p (0.4)	AFP (20 ng/ml)	miR-223-3p and AFP
Stage 0, A (n = 21)	13 (61.9)	12 (57.1)	18 (85.7)
Stage B (n = 24)	18 (75.0)	15 (62.5)	24 (100)
Stage C,D (n = 25)	25 (100)	16 (64.0)	25 (100)

Data expressed as n (%)